Join Dr. Madanat (UT Southwestern, Texas), Dr. Stahl (Harvard Medical School, Massachusetts), and Dr. Papadantonakis (Emory University, Georgia) as they break down key Myelodysplastic Syndromes (MDS) abstracts from the 2024 American Society of Hematology (ASH) meeting.<br /><br />Tune in to gain valuable insights and stay informed about the evolving landscape of MDS management.

Join Dr. Madanat (UT Southwestern, Texas), Dr. Stahl (Harvard Medical School, Massachusetts), and Dr. Papadantonakis (Emory University, Georgia) as they break down key Myelodysplastic Syndromes (MDS) abstracts from the 2024 American Society of Hematology (ASH) meeting.Tune in to gain valuable insights and stay informed about the evolving landscape of MDS management.

Join Dr. Madanat (UT Southwestern, Texas), Dr. Stahl (Harvard Medical School, Massachusetts), and Dr. Papadantonakis (Emory University, Georgia) as they break down key Myelodysplastic Syndromes (MDS) abstracts from the 2024 American Society of Hematology (ASH) meeting.<br><br>Tune in to gain valuable insights and stay informed about the evolving landscape of MDS management.

ASH 2024: MDS in Focus [MDS Patient & Family Report]

This new initiative of the MDS Foundation is devoted to patients, family members, and other non-professional interested people. In each episode, experts in the field will discuss novel information on MDS, such as new diagnostic techniques, new therapies etc. They will also answer frequently asked questions, which are relevant to many people.

Share ASH 2024: MDS in Focus [MDS Patient & Family Report]

Sign up to save your podcasts

ASH 2024: MDS in Focus [MDS Patient & Family Report]

ASH 2024: MDS in Focus [MDS Patient & Family Report]